Congenital heart defects in adults.please provide each defects under this headings

Etiology Epidemiology Pathophysiology Clinical signs and symptoms Diagnosis Differential diagnosis Treatment Complications Prevention

Reading File

Finding Sources

Searching the Web

congenital heart defects in adults etiology pathophysiology clinical signs diagnosis treatment 2024

Reading File

Finding Sources

Reading File

Reading Web Page

congenital heart defects adults etiology pathophysiology clinical signs diagnosis treatment complications

Reading File

Finding Sources

Reading File

I now have comprehensive material from Goldman-Cecil Medicine covering all the major congenital heart defects in adults. I have enough to compose a thorough, well-structured answer covering each defect under all 9 requested headings.

Congenital Heart Defects in Adults

Adult congenital heart disease (ACHD) encompasses all structural cardiac anomalies present at birth that are encountered in the adult population. An estimated 2.4 million people currently live with CHD in the United States, two thirds of whom are adults. Below, each major defect is described under the nine requested headings.

1. ATRIAL SEPTAL DEFECT (ASD)

Etiology

ASDs arise from failure of the interatrial septum to close properly during embryogenesis. Subtypes include:

Ostium secundum (most common, 70%) - deficiency in the fossa ovalis region
Ostium primum - failure of endocardial cushion fusion (associated with Down syndrome/trisomy 21)
Sinus venosus - near the superior or inferior vena cava
Coronary sinus - rare, associated with persistent left SVC

Genetic associations include Turner syndrome (45,X), trisomy 21, and CATCH-22 syndromes (22q11 deletion). Environmental risk factors include maternal diabetes, rubella infection in the first trimester, alcohol use, and thalidomide exposure.

Epidemiology

ASDs constitute 30-40% of all congenital heart disease in adults. Ostium secundum accounts for 7% of all congenital lesions. ASDs are more common in females (2:1). They are the most frequently diagnosed CHD in adults because many remain asymptomatic until the 4th-5th decade.

Pathophysiology

A defect in the interatrial septum creates a left-to-right shunt (since left atrial pressure exceeds right atrial pressure). This results in:

Right atrial and right ventricular volume overload
Increased pulmonary blood flow (Qp:Qs ratio >1.5:1 is significant)
Progressive pulmonary arterial hypertension over decades
Right ventricular dilation and eventual right heart failure
Risk of paradoxical embolism (right-to-left shunting across the defect)
Development of atrial arrhythmias (AF, flutter) from chronic right atrial dilation
Eisenmenger syndrome in long-standing, large, unrepaired ASDs (reversal to right-to-left shunt)

Clinical Signs and Symptoms

Most patients are minimally symptomatic in the first three decades; >70% become impaired by the fifth decade.

Symptoms: Exercise intolerance, dyspnea on exertion, fatigue, palpitations, syncope, stroke/TIA (paradoxical embolism)

Signs:

Right ventricular heave (left parasternal area)
Wide and fixed splitting of S2 (hallmark - does not vary with respiration)
Soft midsystolic pulmonary flow murmur (2nd left interspace)
Mid-diastolic tricuspid flow murmur (lower left sternal border) with large shunts
Signs of right heart failure in advanced disease (elevated JVP, peripheral edema)

Diagnosis

ECG: Incomplete right bundle branch block (rSr' pattern in V1/V2); right axis deviation; prolonged PR interval; atrial fibrillation/flutter in older patients
Chest X-ray: Pulmonary plethora, dilated pulmonary artery and branches, right atrial and RV enlargement
Echocardiography (TTE/TEE): Diagnostic - directly visualizes the defect, estimates shunt ratio (Qp:Qs), measures pulmonary artery pressure. Sinus venosus ASDs may require TEE. Saline contrast ("bubble study") detects shunting
Cardiac MRI: Quantifies shunt volume and RV function
Cardiac catheterization: Measures pulmonary vascular resistance when pulmonary hypertension is suspected

Differential Diagnosis

Patent foramen ovale (PFO) - no resting shunt, different echocardiographic appearance
Pulmonary stenosis (similar murmur, but S2 splitting is not fixed)
Partial anomalous pulmonary venous return (often coexists with sinus venosus ASD)
Right heart failure from other causes
Mitral stenosis (mid-diastolic murmur)

Treatment

Closure is indicated when there is right-sided heart enlargement (with or without symptoms):

Percutaneous transcatheter closure (Amplatzer device): For centrally located secundum ASDs up to 3.5 cm. Avoids sternotomy and cardiopulmonary bypass. Preferred first-line approach
Surgical closure: For large defects, sinus venosus ASDs, primum ASDs requiring concomitant valve repair, or when anatomy is unsuitable for device closure
Contraindication: Eisenmenger syndrome (fixed pulmonary hypertension with right-to-left shunt) - closure worsens outcome
Post-closure: Antiplatelet therapy (aspirin) for 6 months after device closure; endocarditis prophylaxis not routinely required

In patients >40 years with symptoms and significant shunts, closure improves functional status and survival.

Complications

Atrial fibrillation and flutter (most common long-term complication)
Pulmonary arterial hypertension and Eisenmenger syndrome
Right heart failure
Paradoxical embolism and stroke
Post-closure: Device embolization, residual shunt, device-related thrombus, atrial arrhythmias (may persist even after closure in older patients)

Prevention

Folic acid supplementation during pregnancy reduces risk of many cardiac defects
Avoidance of teratogens (alcohol, rubella vaccination before pregnancy, avoidance of thalidomide)
Genetic counseling for families with known CHD or chromosomal syndromes

2. PATENT FORAMEN OVALE (PFO)

Etiology

The foramen ovale is a normal fetal interatrial communication. Failure of the septum primum to fuse with the septum secundum after birth results in a PFO. It is present in approximately 25-30% of the general population. It is not a true structural defect but a variant of normal closure failure.

Epidemiology

PFO is the most common interatrial communication in adults. Cryptogenic stroke in patients <55 years is strongly associated with PFO (found in up to 40-50% of such cases), compared with ~25% in the general population.

Pathophysiology

A PFO has no resting shunt (flap valve mechanism). Right-to-left shunting occurs transiently when right atrial pressure transiently exceeds left atrial pressure (Valsalva maneuver, cough, straining). This allows venous thrombi, air, or fat to bypass the pulmonary circulation and enter the systemic circulation, causing paradoxical embolism and cryptogenic stroke. No significant volume load is placed on the heart chambers.

Clinical Signs and Symptoms

Usually asymptomatic on examination
No detectable physical findings
May present with cryptogenic stroke, TIA, or peripheral embolism
Association with platypnea-orthodeoxia syndrome (desaturation and dyspnea when upright, relieved when supine) in patients with right-to-left shunting through a PFO
Migraine with aura has a weak association

Diagnosis

No ECG or chest X-ray abnormalities
Transoesophageal echocardiography (TEE) with bubble study (agitated saline + Valsalva maneuver): Gold standard - detects right-to-left shunt across the foramen during Valsalva
TTE with contrast can screen but TEE is more sensitive
Right heart catheterization if pulmonary hypertension needs exclusion

Differential Diagnosis

Secundum ASD (larger defect with fixed S2 splitting, right heart dilation)
Other causes of cryptogenic stroke (thrombophilia, atrial fibrillation, arterial dissection)
Hereditary hemorrhagic telangiectasia (pulmonary AV fistulas)

Treatment

Antiplatelet therapy (aspirin): For asymptomatic PFO
Anticoagulation: For patients with deep vein thrombosis/PE and cryptogenic stroke
Percutaneous PFO closure: Indicated in cryptogenic stroke with confirmed PFO in patients aged 18-65 years, without other identifiable cause; reduces recurrent stroke vs. medical therapy alone (based on CLOSE, REDUCE, RESPECT trials)
No closure if PFO is incidental finding without symptoms

Complications

Cryptogenic stroke and TIA
Paradoxical air or fat embolism
Decompression sickness in divers

Prevention

Genetic counseling is not applicable (PFO is not purely genetic)
Avoid Valsalva-inducing activities in known high-risk patients
Screening for DVT in patients with PFO and cryptogenic stroke

3. VENTRICULAR SEPTAL DEFECT (VSD)

Etiology

VSDs result from failure of the interventricular septum to close completely during cardiac embryogenesis. Subtypes:

Perimembranous (most common, 70%) - near the aortic valve
Muscular - within trabecular portion, may be multiple ("Swiss cheese")
Outlet (supracristal/doubly committed) - beneath the aortic/pulmonary valve; associated with aortic regurgitation
Inlet (AV canal type) - associated with trisomy 21

Chromosomal associations: trisomy 21 (~40%), trisomy 13 (90%), trisomy 18 (90%). Also associated with DiGeorge syndrome (22q11 deletion).

Epidemiology

VSD is the most common congenital heart lesion overall (15-20% of all CHD in children). However, its prevalence in adults is lower due to the high rate of spontaneous closure (30-50% of small VSDs close by age 10). In adults, VSD represents a smaller proportion of CHD. A solitary VSD represents 15-20% of all congenital lesions.

Pathophysiology

Left-to-right shunting through the VSD increases pulmonary blood flow, causing:

Left ventricular volume overload and dilation
Increased pulmonary flow - over time leads to pulmonary vascular disease
Eisenmenger syndrome in large, unrepaired VSDs (reversal to right-to-left shunt with cyanosis)
Small VSDs - hemodynamically insignificant but carry risk of infective endocarditis
Subarterial outlet VSDs may cause progressive aortic regurgitation from leaflet prolapse

Clinical Signs and Symptoms

Small VSD ("maladie de Roger"): Asymptomatic; loud pansystolic murmur at left sternal border
Moderate-large VSD: Dyspnea, fatigue, exercise intolerance, recurrent respiratory infections (in infancy/childhood); in adults, symptoms of left heart failure
Eisenmenger VSD: Cyanosis, clubbing, polycythemia, dyspnea at rest, right heart failure, hemoptysis
Signs: Harsh holosystolic murmur at 3rd-4th left intercostal space (louder with smaller defects); thrill with smaller defects; displaced apex (LV dilation); S3 with large shunts

Diagnosis

ECG: Left ventricular hypertrophy (volume overload pattern); biventricular hypertrophy with large shunts
Chest X-ray: Cardiomegaly, increased pulmonary vascular markings, dilated pulmonary artery
Echocardiography: Diagnostic - localizes defect, estimates size, measures shunt ratio and pulmonary pressure via Doppler
Cardiac catheterization: Quantifies pulmonary vascular resistance; assesses reversibility in pulmonary hypertension

Differential Diagnosis

Aortic stenosis (ejection murmur, not holosystolic)
Mitral regurgitation (murmur radiates to axilla)
Hypertrophic obstructive cardiomyopathy
Tricuspid regurgitation

Treatment

Observation: Small defects with no hemodynamic significance
Surgical or transcatheter closure: Indicated when Qp:Qs ≥2:1, or with evidence of LV volume overload; also for subarterial VSDs with progressive aortic regurgitation
Eisenmenger syndrome: Closure is contraindicated; management includes pulmonary vasodilators (bosentan, sildenafil, prostacyclins), supportive care
Endocarditis prophylaxis: Recommended for 6 months post-repair (device or surgical)

Complications

Infective endocarditis (even small VSDs)
Pulmonary arterial hypertension and Eisenmenger syndrome
Aortic regurgitation (outlet VSDs)
Heart failure
Ventricular arrhythmias post-repair
Complete heart block (surgical complication near AV node)

Prevention

Same general measures as ASD (folic acid, avoidance of teratogens)
Genetic counseling in chromosomal syndromes

4. PATENT DUCTUS ARTERIOSUS (PDA)

Etiology

The ductus arteriosus is a normal fetal vessel connecting the main pulmonary artery to the descending aorta near the left subclavian artery origin. Failure of postnatal closure (normally functional closure within 24-48 hours in term infants via prostaglandin fall and oxygen rise) results in PDA. Risk factors include:

Prematurity (most significant)
Maternal rubella infection (first trimester)
High altitude birth
Female sex (3:1 female predominance)
PDA accounts for 5-10% of all congenital cardiac lesions in infants with normal birthweight

Epidemiology

PDA accounts for 5-10% of all CHD. More common in females (3:1). Increased prevalence at high altitudes. In adults, an unrepaired PDA surviving to adulthood is typically small or already associated with pulmonary hypertension.

Pathophysiology

The physiologic consequence depends on the size and the pulmonary-to-systemic vascular resistance ratio:

Small PDA: Continuous left-to-right shunt; no cardiac dilation; no symptoms but risk of endarteritis (~0.45%/year after second decade)
Moderate-large PDA: Continuous aortopulmonary flow causes left atrial and LV volume overload; elevated pulmonary blood flow progressively damages the pulmonary vasculature
Eisenmenger PDA: Pulmonary pressure equals or exceeds systemic; shunt reverses to right-to-left; deoxygenated blood from the pulmonary artery enters the descending aorta, causing differential cyanosis (lower limbs more cyanosed than upper limbs)

Clinical Signs and Symptoms

Small PDA: Asymptomatic
Moderate-large PDA: Dyspnea, palpitations, exercise intolerance (2nd-3rd decade)
Large PDA: Signs of left heart failure; bounding pulse (wide pulse pressure); tachycardia

Signs:

"Machinery murmur" (continuous, crescendo-decrescendo) heard below left clavicle at 1st-2nd left intercostal space (pathognomonic)
Bounding, collapsing pulse (wide pulse pressure)
Left ventricular heave
With Eisenmenger: murmur disappears; differential cyanosis (toes cyanotic, fingers normal); clubbing of toes

Diagnosis

ECG: Left ventricular hypertrophy; biventricular with pulmonary hypertension
Chest X-ray: Dilated ascending aorta and pulmonary artery; left-sided cardiac enlargement; pulmonary plethora; calcification at PDA site in older patients
Echocardiography/Doppler: Identifies ductal flow; left chamber size; estimates pulmonary pressure. May not directly visualize duct but Doppler signal in main pulmonary artery is diagnostic
Cardiac catheterization: Required before closure to assess pulmonary vascular resistance

Differential Diagnosis

Aortopulmonary window (continuous murmur but in different location)
Venous hum (abolished by neck compression or supine position)
Coronary AV fistula
Ruptured sinus of Valsalva aneurysm
Peripheral pulmonary artery stenosis

Treatment

Indomethacin/Ibuprofen: Effective in premature infants (prostaglandin synthesis inhibitors)
Transcatheter closure (coil embolization or Amplatzer Duct Occluder): First choice in suitable anatomy; closure indicated for left-sided heart enlargement or prior endarteritis
Surgical ligation: When transcatheter approach is not feasible
Contraindication: Eisenmenger syndrome; irreversible pulmonary hypertension
If pulmonary artery pressure/resistance substantially elevated, pre-closure evaluation of reversibility is mandatory
Pulmonary vasodilators (sildenafil, bosentan, prostacyclins) for Eisenmenger syndrome palliation

Complications

Infective endarteritis (0.45%/year for small PDAs)
Eisenmenger syndrome (5% of isolated PDA)
Left heart failure
Pulmonary arterial hypertension
Differential cyanosis and clubbing (toes > fingers)
Mortality 3-4%/year by 4th decade if untreated large PDA; 2/3 of patients die by age 60

Prevention

Antenatal care and avoidance of perinatal hypoxia in premature infants
Maternal rubella vaccination
Indomethacin/indomethacin prophylaxis in high-risk premature neonates

5. PULMONARY STENOSIS (PS)

Etiology

Obstruction to right ventricular outflow may be:

Valvular PS (most common) - dysplastic or domed pulmonary valve; associated with Noonan syndrome (50% of cases), congenital rubella
Subvalvular (infundibular) - hypertrophy of RV outflow tract; often seen with VSD
Supravalvular - associated with Williams syndrome, rubella syndrome

Genetic: Noonan syndrome (PTPN11, RAF1 mutations), Williams syndrome (ELN deletion), congenital rubella.

Epidemiology

PS represents 3-10% of all congenital cardiac lesions. Valvular PS accounts for 80-90% of RVOT obstruction. PS is the most common form of right-sided obstructive lesion. Mild PS is often asymptomatic and discovered incidentally in adults.

Pathophysiology

Fixed obstruction to RV outflow causes:

RV pressure overload and concentric RV hypertrophy
Inability to increase pulmonary blood flow during exercise - exercise intolerance
Inadequate myocardial perfusion (demand > supply) - angina
Ventricular arrhythmias and sudden death in severe cases
Post-stenotic dilation of the main pulmonary artery
Severe PS with infundibular hypertrophy can cause RV failure; right-to-left shunting through an ASD or PFO may develop

Clinical Signs and Symptoms

Mild PS: Usually asymptomatic; discovered on murmur auscultation
Moderate-severe PS: Exercise intolerance, exertional dyspnea, fatigue, exertional syncope, angina
Right heart failure: Peripheral edema, ascites, hepatomegaly (advanced)

Signs:

Ejection click (best heard in expiration at upper left sternal border) - pulmonary ejection click
Harsh ejection systolic murmur at upper left sternal border, radiating to left shoulder/back
Murmur intensity does not reliably predict severity; rather, the later the peak, the more severe
RV heave (pressure overloaded RV)
Wide splitting of S2 with soft or absent P2 in severe PS
Signs of right heart failure in advanced cases

Diagnosis

ECG: Right axis deviation; right ventricular hypertrophy (tall R in V1, deep S in V5-V6)
Chest X-ray: Post-stenotic dilation of the main pulmonary artery; normal or reduced pulmonary vascular markings; RV enlargement
Echocardiography/Doppler: Diagnostic - estimates gradient across RVOT/pulmonary valve. Mild PS: peak gradient <36 mmHg; Moderate: 36-64 mmHg; Severe: >64 mmHg
Cardiac catheterization: May be combined with balloon valvuloplasty; used when Doppler findings are inconclusive

Differential Diagnosis

ASD (fixed splitting of S2, but no ejection click; pulmonary flow murmur is different)
Hypertrophic obstructive cardiomyopathy (LVOT obstruction; different murmur characteristics)
Aortic stenosis (right sternal border, radiates to carotids)
Ventricular septal defect (holosystolic murmur)

Treatment

Observation: Mild PS (gradient <36 mmHg) with no symptoms
Balloon valvuloplasty (percutaneous): First-line for valvular PS with peak gradient >64 mmHg or symptoms; also for moderate PS with RV dysfunction
Surgical valvotomy/valve replacement: For dysplastic valves not amenable to balloon dilation; subvalvular PS
Excellent prognosis after successful intervention; normal life expectancy in most cases

Complications

RV failure
Atrial arrhythmias (from right atrial dilation)
Infective endocarditis
Sudden cardiac death (in severe, untreated cases)
Pulmonary regurgitation after valvuloplasty (usually well tolerated)

Prevention

Noonan syndrome genetic counseling
Rubella vaccination in women of childbearing age

6. COARCTATION OF THE AORTA

Etiology

Coarctation is a discrete narrowing of the aorta, typically at or just distal to the insertion of the ductus arteriosus (juxtaductal), in the region of the aortic isthmus. Associated conditions include:

Bicuspid aortic valve (50-85% of coarctation cases)
Turner syndrome (45,X) - most frequently associated chromosomal defect
Berry aneurysms of the circle of Willis (5-10%)
VSD, PDA, mitral valve anomalies

Genetic: Turner syndrome, mutations in NOTCH1, NKX2.5. Also associated with ELN mutations (Williams syndrome - though more often peripheral PS).

Epidemiology

Coarctation represents 5-8% of all CHD. More common in males (2:1). Estimated prevalence 4 per 10,000 live births. It is the most common cause of secondary hypertension in young adults due to a structural cause.

Pathophysiology

Obstruction in the descending aorta creates a pressure gradient - systemic hypertension in the upper extremities
Left ventricular pressure overload and LVH
Reduced perfusion to the lower body - lower extremity claudication
Collateral circulation develops over time (via intercostal, internal mammary arteries) - rib notching
Associated bicuspid aortic valve may develop stenosis or regurgitation independently
Persistent hypertension leads to premature coronary artery disease, LV failure, aortic dissection, cerebrovascular accidents
Berry aneurysms of the circle of Willis risk rupture - intracranial hemorrhage

Clinical Signs and Symptoms

Symptoms: Headache, epistaxis (hypertension), upper extremity claudication, lower extremity claudication with exercise, cold feet, dizziness, exertional dyspnea

Characteristic signs:

Hypertension in upper extremities with lower or absent blood pressure in lower extremities (>20 mmHg differential between arms and legs)
Radiofemoral delay (radial pulse precedes femoral pulse)
Decreased or absent femoral/foot pulses
Visible collateral pulsations in the neck and back
Systolic ejection murmur heard over left sternal border and in the back (interscapular area)
Aortic regurgitation murmur if bicuspid aortic valve is diseased

Diagnosis

ECG: Left ventricular hypertrophy
Chest X-ray:
- "3 sign" (dilated subclavian artery above, poststenotic aortic dilation below the coarctation)
- Rib notching (bilateral, 4th-8th ribs) from dilated intercostal collaterals - seen in adults
- Prominent ascending aorta
Echocardiography/Doppler: Estimates gradient across coarctation; associated bicuspid aortic valve; LVH; suprasternal view best
MRI/CT angiography: Definitive imaging - delineates anatomy, extent, and collaterals; preferred for surgical/interventional planning
Cardiac catheterization: Measures gradient; used at time of intervention

Differential Diagnosis

Essential hypertension (no pulse differential; no rib notching)
Takayasu arteritis (may involve the aorta; inflammatory markers elevated)
Aortic dissection
Middle aortic syndrome (uncommon; affects midabdominal aorta)
Bicuspid aortic valve without coarctation

Treatment

Surgical repair: Resection and end-to-end anastomosis, patch angioplasty, or bypass graft; traditionally preferred for complex anatomy
Percutaneous balloon angioplasty with stenting: Increasingly preferred for adults and for re-coarctation after prior surgical repair; stenting reduces risk of aneurysm formation
Timing: Repair recommended at time of diagnosis regardless of symptoms due to risks of untreated hypertension
Lifelong follow-up: Even after repair, hypertension may persist; risk of re-coarctation, aortic aneurysm, bicuspid AV disease, and intracranial aneurysm remains
Antihypertensive therapy (ACE inhibitors, beta-blockers) for residual/persistent hypertension

Complications

Systemic hypertension (even after repair)
Premature coronary artery disease
Aortic dissection and aortic aneurysm (at coarctation site or ascending aorta)
Intracranial aneurysm rupture (subarachnoid hemorrhage)
Stroke
LV failure
Re-coarctation after repair
Paradoxical hypertension post-repair (risk of mesenteric arteritis)
Infective endocarditis

Prevention

Genetic screening in Turner syndrome patients for aortic coarctation
Folic acid and teratogen avoidance in pregnancy
Lifelong cardiology follow-up after repair for surveillance

7. TETRALOGY OF FALLOT (TOF)

Etiology

TOF results from anterior malalignment of the infundibular (outlet) septum during development. The four classic components are:

Right ventricular outflow tract obstruction (infundibular/subpulmonary stenosis)
Ventricular septal defect (large, perimembranous)
Overriding aorta
Right ventricular hypertrophy (secondary)

Genetic associations: 22q11 deletion (DiGeorge/CATCH-22) in ~15% (higher with right aortic arch); trisomy 21; CHARGE association; JAG1 mutations (Alagille syndrome). Sporadic in most cases. Maternal diabetes and phenylketonuria increase risk.

Epidemiology

TOF is the most common cyanotic congenital anomaly in adults and accounts for 5-10% of all CHD. It is the single most common reason for surgical correction and is the most common lesion adults with "corrected" complex CHD carry. Without surgery, <5% survive to age 40.

Pathophysiology

Unrepaired TOF:

The VSD is large and non-restrictive, equalizing LV and RV pressures
Severity of RVOT obstruction determines the degree of right-to-left shunting
RVOT obstruction diverts deoxygenated RV blood through the VSD into the overriding aorta - causing systemic cyanosis
Progressive RV hypertrophy
"Tet spells" (hypercyanotic spells) in infancy from dynamic infundibular spasm

Repaired TOF (common in adult patients):

Patch closure of VSD eliminates shunting
RVOT relief (resection/patch/transannular patch) causes chronic pulmonary regurgitation - progressive RV dilation and dysfunction
Risk of right bundle branch block and VT/VF from RV scar

Clinical Signs and Symptoms

Unrepaired (rare in adults):

Central cyanosis, clubbing of digits
Exertional dyspnea, exercise intolerance
Polycythemia (compensatory)
Squatting behavior (increases SVR, reduces right-to-left shunt)

Repaired TOF (most adults):

Many are initially well
Progressive exertional dyspnea and reduced exercise tolerance
Palpitations (ventricular arrhythmias from RV scar)
Presyncope/syncope (sustained VT)
Signs of RV failure (JVP elevation, peripheral edema, hepatomegaly)
Diastolic murmur of pulmonary regurgitation at left sternal border
Surgical scar on chest; possible thrill over RVOT

Diagnosis

ECG: Right bundle branch block (RBBB) after repair (nearly universal); QRS duration >180 ms is a risk marker for VT/sudden death; right axis deviation
Chest X-ray: "Boot-shaped heart" (coeur en sabot) in unrepaired cases; right aortic arch in 25%; post-repair - RV enlargement, absent or small pulmonary artery segment
Echocardiography: Assesses residual VSD, RVOT obstruction, severity of pulmonary regurgitation, RV size and function
Cardiac MRI: Gold standard for quantifying pulmonary regurgitation fraction and RV volumes (key for deciding pulmonary valve replacement timing)
Holter/electrophysiology study: Risk-stratification for VT; indicated before pulmonary valve replacement in those with QRS >160 ms

Differential Diagnosis

Other cyanotic CHD (transposition, truncus arteriosus, pulmonary atresia)
Double outlet right ventricle with pulmonary stenosis (may be mistaken for TOF)
Pentalogy of Cantrell
Post-repair cardiomyopathy

Treatment

Complete surgical repair is standard in childhood (VSD patch + RVOT relief)
Pulmonary valve replacement (PVR): Indicated in repaired TOF adults with severe pulmonary regurgitation and RV dilation (RV end-diastolic volume index >160-170 mL/m² or worsening RV dysfunction, exercise intolerance)
Transcatheter pulmonary valve implantation (Melody, SAPIEN valves): Growing role, especially in conduit-RVOT anatomy
Antiarrhythmic therapy/ICD: For sustained VT; VT ablation in selected patients
ICD implantation: For survivors of cardiac arrest, sustained VT, or high-risk features (QRS >180 ms, severe pulmonary regurgitation, LV dysfunction, syncope)

Complications

Pulmonary regurgitation with progressive RV dilation and failure (most common long-term complication)
Ventricular tachycardia and sudden cardiac death
Residual or recurrent RVOT obstruction
Residual VSD
Atrial arrhythmias (AF, flutter)
Aortic root dilation and aortic regurgitation
Infective endocarditis
Brain abscess (from paradoxical emboli in unrepaired/cyanotic disease)
Polycythemia with hyperviscosity

Prevention

Periconceptional folic acid supplementation
Genetic counseling and screening for 22q11 deletion in affected families
Avoidance of known teratogens
Timely complete surgical repair in infancy/childhood

8. TRANSPOSITION OF THE GREAT ARTERIES (TGA)

Etiology

TGA results from abnormal septation and rotation of the truncoaortic sac during embryogenesis. Two main types:

D-TGA (Complete TGA): Aorta arises from the morphological RV; pulmonary artery arises from the morphological LV - parallel (non-crossing) circulation. Incompatible with postnatal life without mixing (ASD, VSD, or PDA)
L-TGA (Congenitally Corrected TGA, ccTGA): Ventricular inversion with great artery transposition; "physiologically" corrected - systemic venous blood still reaches the lungs and pulmonary venous blood reaches the aorta, but the morphological RV is the systemic pumping chamber

Sporadic in most cases; associated with maternal diabetes, solvent exposure.

Epidemiology

TGA (D-TGA) accounts for approximately 5% of all CHD and is the most common cyanotic defect presenting in the neonatal period. Without treatment, >90% die in the first year. Adults with D-TGA have almost universally undergone surgical repair. The adult population with TGA predominantly represents those who had:

Mustard or Senning atrial switch repair (older operations - still the majority of current adults with D-TGA)
Arterial switch operation (ASO/Jatene) - done since the 1980s; these patients are now entering adulthood

Pathophysiology

D-TGA (unrepaired):

Parallel rather than series circulation - systemic venous blood recirculates systemically; pulmonary venous blood recirculates to lungs
Survival depends on mixing through ASD, VSD, or PDA

Post-Mustard/Senning (atrial switch):

Pulmonary venous blood baffled through the tricuspid valve to the morphological RV (systemic RV)
Systemic venous blood baffled to the morphological LV
The morphological RV bears systemic afterload - progressive systemic RV failure over decades
Baffle obstruction and leaks
Sinus node dysfunction and atrial arrhythmias (from extensive atrial surgery)

Post-arterial switch (ASO):

Anatomically corrected - morphological LV pumps to the aorta; LV is the systemic ventricle
Concerns include: neo-aortic root dilation, coronary artery ostial stenosis (from reimplantation), pulmonary stenosis

L-TGA (ccTGA):

Morphological RV is the systemic ventricle; progressive systemic RV failure over time (often in 4th-5th decade)
Associated defects common: VSD (80%), pulmonary stenosis (50%), Ebstein anomaly of the systemic (left) AV valve (30%)
Progressive AV block (complete heart block in up to 2%/year)

Clinical Signs and Symptoms

Post-Mustard/Senning adults:

Progressive dyspnea, fatigue, reduced exercise capacity
Palpitations (atrial flutter/fibrillation, VT)
Syncope (sinus node dysfunction, brady- or tachyarrhythmias)
Signs of systemic (RV) ventricular failure: raised JVP, peripheral edema, hepatomegaly, tricuspid regurgitation murmur
Cyanosis if baffle leak

L-TGA (ccTGA):

May be asymptomatic for decades
Symptoms of systemic RV failure
Complete heart block (palpitations, syncope)
Symptoms of associated defects (VSD, PS)

Diagnosis

ECG: Q waves in V1; absent Q waves in lateral leads (from ventricular inversion in ccTGA); bradyarrhythmias (complete heart block in ccTGA); atrial flutter/fibrillation in post-atrial switch patients
Chest X-ray: Narrow mediastinal waist (parallel great vessels in D-TGA); cardiomegaly in systemic RV failure
Echocardiography: Identifies morphological RV as systemic ventricle; assesses systemic ventricular function; baffle stenosis or leaks; tricuspid (systemic AV valve) regurgitation
Cardiac MRI: Gold standard for quantifying systemic RV volumes and function; evaluates great vessel anatomy; coronary anatomy post-ASO
Electrophysiologic study: For sinus node dysfunction and atrial/ventricular arrhythmias

Differential Diagnosis

Other cyanotic CHD (TOF, truncus arteriosus)
Dilated cardiomyopathy (in the context of systemic RV failure)
Arrhythmogenic right ventricular cardiomyopathy

Treatment

Post-Mustard/Senning:

Pacemaker/ICD: Sinus node dysfunction is common; prophylactic pacing; ICD for VT/sudden death risk
Heart failure therapy: ACE inhibitors, beta-blockers for systemic RV failure (evidence less robust than for LV failure)
Baffle intervention: Stenting or surgical repair for baffle obstruction; device closure for leaks
Cardiac transplantation: End-stage systemic RV failure
"Double switch" operation (atrial + arterial switch): May be considered in selected patients with ccTGA to restore LV as systemic ventricle, but high surgical risk in adults

Post-ASO:

Surveillance for neo-aortic root dilation (aortic valve repair/replacement if severe AR)
Coronary CT angiography for ostial stenosis
Pulmonary stenosis intervention if significant

L-TGA (ccTGA):

Pacemaker for complete heart block
Pulmonary vasodilators/HF therapy for systemic RV failure
Surgical repair of associated defects

Complications

Post-atrial switch (Mustard/Senning):

Systemic RV failure (leading cause of late morbidity/death)
Sinus node dysfunction and bradyarrhythmias
Atrial flutter and fibrillation
Baffle obstruction (superior or inferior vena cava pathway)
Baffle leaks with cyanosis
Sudden cardiac death (VT/VF)

ccTGA:

Progressive complete heart block (~2%/year)
Systemic (morphological RV) failure
Tricuspid (systemic AV valve) regurgitation
Sudden cardiac death

Prevention

Avoidance of maternal diabetes and teratogens during early pregnancy
Genetic counseling
Timely surgical repair (ideally ASO in the neonatal period) in D-TGA provides the best long-term outcome

9. EBSTEIN ANOMALY

Etiology

Ebstein anomaly results from failure of delamination of the tricuspid valve leaflets from the RV myocardium during embryogenesis. The septal and posterior leaflets are apically displaced into the RV, creating an "atrialized" RV. The anterior leaflet is elongated and sail-like. Associated with:

Maternal lithium exposure (historically overestimated but a recognized risk factor)
WPW (Wolff-Parkinson-White) syndrome (accessory pathways, especially right-sided, in ~25% of cases)
ASD or PFO (in >80% of cases)
TOF, pulmonary stenosis/atresia

Sporadic in most cases; NKX2.5 mutations rarely implicated.

Epidemiology

Ebstein anomaly accounts for less than 1% of all CHD (approximately 1 per 20,000 live births). It spans a wide clinical spectrum - mild cases may be detected incidentally in adults. Accounts for 0.5% of all ACHD.

Pathophysiology

Atrialization of the RV: The portion of RV between the true AV ring and the apically displaced leaflets contracts paradoxically with the right atrium, reducing effective RV pump function
Tricuspid regurgitation: Malformed valve leads to severe TR, causing marked right atrial dilation
Right-to-left shunting: Through ASD/PFO when right atrial pressure exceeds left (causes cyanosis)
Accessory pathways: WPW accessory pathways cause pre-excitation and risk of supraventricular tachycardia and AF with rapid conduction
Reduced effective RV size decreases pulmonary blood flow

Clinical Signs and Symptoms

Ranges from asymptomatic (mild) to severe neonatal cyanosis
In adults: exercise intolerance, fatigue, palpitations (SVT, AF), dyspnea
Cyanosis and clubbing if right-to-left shunting through ASD
Signs: RV heave; widely split S1 (delayed tricuspid closure); "sail sound" (loud T1 from large anterior leaflet); S3, S4; pan-/holosystolic murmur of TR at left lower sternal border; signs of right heart failure
Pre-excitation on ECG (delta waves) in WPW

Diagnosis

ECG: Right bundle branch block; right atrial enlargement ("Himalayan" P waves); delta waves (WPW); prolonged PR interval; atrial flutter/fibrillation
Chest X-ray: Massive cardiomegaly (predominantly right-sided), "box-shaped" heart; decreased pulmonary vascular markings
Echocardiography: Diagnostic - measures apical displacement of the septal leaflet (>8 mm/m²), assesses TR severity, degree of RV atrialization, RV function, ASD shunting, biventricular function
MRI: Quantifies RV volume; assesses function comprehensively
Electrophysiology study: Identifies accessory pathways before ablation

Differential Diagnosis

Tricuspid regurgitation from other causes (rheumatic, carcinoid)
Dilated cardiomyopathy
Pericardial effusion (large cardiac silhouette)
Arrhythmogenic RV cardiomyopathy (ARVC)

Treatment

Observation: Mild cases; annual follow-up with ACHD specialist
Antiarrhythmic therapy / catheter ablation: For WPW and SVT (ablation preferred, especially before surgery; RFCA or cryoablation of accessory pathway)
ASD closure: Reduce right-to-left shunting and paradoxical embolism risk
Tricuspid valve repair or replacement + RV plication: For symptomatic severe TR (dyspnea, RV failure, cyanosis); TV repair preferred over replacement; "cone reconstruction" (Carpentier/da Silva technique) offers excellent results
Bidirectional Glenn or Fontan procedure: In cases with severely inadequate effective RV
ICD: For ventricular arrhythmias

Complications

Atrial fibrillation and flutter (major cause of morbidity)
SVT via accessory pathways; risk of sudden cardiac death from rapid AF conducted via bypass tract
Right heart failure
Cyanosis and polycythemia
Paradoxical embolism/stroke
Sudden cardiac death

Prevention

Lithium avoidance or minimization in first trimester of pregnancy
Genetic counseling
WPW ablation prior to pregnancy or sports in high-risk patients

GENERAL OVERVIEW: COMMON THEMES ACROSS ALL DEFECTS

Heading	Common Thread
Etiology	Multifactorial: chromosomal (trisomy 21, 22q11, Turner), environmental teratogens (rubella, diabetes, alcohol), sporadic gene mutations
Epidemiology	CHD affects ~1% of births; ~2.4 million US adults live with CHD (2/3 of all CHD patients are now adults)
Pathophysiology	Shunt lesions (L→R), outflow obstruction, cyanotic lesions (R→L), Eisenmenger syndrome (shunt reversal)
Diagnosis	ECG + chest X-ray (initial); echocardiography (primary imaging); MRI (gold standard for complex anatomy/RV quantification); catheterization for hemodynamics
Treatment	Percutaneous or surgical repair of the primary defect; management of arrhythmias, HF, pulmonary hypertension; Eisenmenger physiology is a contraindication to closure
Complications	Pulmonary hypertension, arrhythmias, ventricular failure, infective endocarditis, paradoxical embolism, sudden cardiac death
Prevention	Folic acid supplementation, avoidance of teratogens, rubella vaccination, genetic counseling in affected families
All adults with CHD	Require lifelong follow-up at specialized ACHD centers (AHA/ACC 2018 and 2025 guidelines)

Sources: Goldman-Cecil Medicine, 26th Edition (Chapter 55 - Congenital Heart Disease in Adults); PMC11224996 (Congenital Heart Disease: Types, Pathophysiology, Diagnosis and Treatment, 2024); AHA/ACC 2025 ACHD Guideline.

Can you concise same for me

Congenital Heart Defects in Adults — Concise Summary

1. ATRIAL SEPTAL DEFECT (ASD)

Heading	Key Points
Etiology	Failed interatrial septal closure; subtypes: secundum (most common), primum, sinus venosus. Associated with trisomy 21, Turner syndrome, 22q11 deletion
Epidemiology	30-40% of adult CHD; female predominance (2:1); most common CHD diagnosed in adults
Pathophysiology	Left-to-right shunt → RV volume overload → pulmonary hypertension → Eisenmenger syndrome (late)
Signs & Symptoms	Dyspnea on exertion, fatigue, palpitations; wide fixed splitting of S2; pulmonary flow murmur; RV heave
Diagnosis	ECG: incomplete RBBB; CXR: pulmonary plethora; Echo: diagnostic (shunt ratio, PA pressure)
Differential Dx	PFO, pulmonary stenosis, partial anomalous pulmonary venous return, mitral stenosis
Treatment	Percutaneous device closure (1st line) or surgical closure if right heart enlargement; contraindicated in Eisenmenger
Complications	Atrial fibrillation, pulmonary hypertension, Eisenmenger, paradoxical embolism, right heart failure
Prevention	Folic acid in pregnancy; avoid teratogens; rubella vaccination; genetic counseling

2. PATENT FORAMEN OVALE (PFO)

Heading	Key Points
Etiology	Failure of septum primum to fuse with septum secundum after birth
Epidemiology	Present in 25-30% of adults; found in ~40-50% of cryptogenic stroke patients <55 years
Pathophysiology	Transient R-to-L shunt during Valsalva → paradoxical embolism; no resting shunt; no cardiac dilation
Signs & Symptoms	Usually asymptomatic; presents with cryptogenic stroke, TIA, or platypnea-orthodeoxia
Diagnosis	TEE with bubble study + Valsalva (gold standard); no ECG or CXR abnormalities
Differential Dx	Secundum ASD, cryptogenic stroke from other causes (AF, thrombophilia)
Treatment	Antiplatelet (aspirin) for asymptomatic; percutaneous closure for cryptogenic stroke aged 18-65 (CLOSE, REDUCE, RESPECT trials)
Complications	Cryptogenic stroke, TIA, paradoxical embolism, decompression sickness in divers
Prevention	Avoid Valsalva-inducing activity in high-risk patients; screen for DVT after cryptogenic stroke

3. VENTRICULAR SEPTAL DEFECT (VSD)

Heading	Key Points
Etiology	Incomplete interventricular septal closure; perimembranous (70%), muscular, outlet, inlet types. Associated with trisomy 21, 13, 18; 22q11 deletion
Epidemiology	Most common CHD in children (15-20%); less prevalent in adults due to high spontaneous closure rates
Pathophysiology	L-to-R shunt → LV volume overload → pulmonary HTN → Eisenmenger; outlet VSD causes aortic regurgitation
Signs & Symptoms	Small VSD: asymptomatic with loud holosystolic murmur; large VSD: dyspnea, fatigue, heart failure; Eisenmenger: cyanosis, clubbing
Diagnosis	ECG: LVH; CXR: cardiomegaly, pulmonary plethora; Echo: localizes defect, estimates shunt/PA pressure
Differential Dx	Mitral regurgitation, aortic stenosis, HOCM, tricuspid regurgitation
Treatment	Observation (small); surgical or transcatheter closure if Qp:Qs ≥2:1 or LV dilation; Eisenmenger: pulmonary vasodilators only
Complications	Infective endocarditis, pulmonary HTN, Eisenmenger, aortic regurgitation (outlet VSD), heart failure
Prevention	Folic acid; teratogen avoidance; genetic counseling in chromosomal syndromes

4. PATENT DUCTUS ARTERIOSUS (PDA)

Heading	Key Points
Etiology	Failed postnatal ductal closure; risk factors: prematurity, maternal rubella, female sex (3:1), high altitude
Epidemiology	5-10% of all CHD; female predominance (3:1)
Pathophysiology	Continuous aorto-pulmonary L-to-R shunt → LV volume overload → pulmonary HTN; Eisenmenger causes differential cyanosis (toes > fingers)
Signs & Symptoms	Small: asymptomatic; large: dyspnea, bounding pulse; classic "machinery murmur" below left clavicle; differential cyanosis in Eisenmenger
Diagnosis	ECG: LVH; CXR: dilated aorta and PA, pulmonary plethora, calcification (adults); Echo/Doppler: diagnostic
Differential Dx	Aortopulmonary window, venous hum, coronary AV fistula, ruptured sinus of Valsalva
Treatment	Indomethacin/ibuprofen (premature infants); transcatheter coil/device closure (adults, 1st line); surgical ligation; contraindicated in Eisenmenger
Complications	Infective endarteritis (0.45%/year), Eisenmenger, LV failure, differential cyanosis; 2/3 die by age 60 if large PDA untreated
Prevention	Antenatal care; rubella vaccination; indomethacin prophylaxis in high-risk premature neonates

5. PULMONARY STENOSIS (PS)

Heading	Key Points
Etiology	Valvular (most common, 80-90%): dysplastic/domed valve; associated with Noonan syndrome, congenital rubella; also subvalvular or supravalvular
Epidemiology	3-10% of all CHD; most common right-sided obstructive lesion; excellent prognosis after treatment
Pathophysiology	Fixed RVOT obstruction → RV pressure overload → RV hypertrophy → inadequate cardiac output on exertion → arrhythmias and sudden death (severe)
Signs & Symptoms	Mild: asymptomatic; moderate-severe: exertional dyspnea, syncope, angina; ejection click + harsh systolic murmur at upper LSB; soft/absent P2; RV heave
Diagnosis	ECG: RVH, right axis deviation; CXR: post-stenotic PA dilation; Echo/Doppler: gradient (mild <36, moderate 36-64, severe >64 mmHg)
Differential Dx	ASD, aortic stenosis, HOCM, VSD
Treatment	Observation if mild; balloon valvuloplasty (1st line) for severe/symptomatic PS; surgery for dysplastic valves or subvalvular stenosis
Complications	RV failure, atrial arrhythmias, infective endocarditis, sudden cardiac death; pulmonary regurgitation post-valvuloplasty
Prevention	Noonan syndrome genetic counseling; rubella vaccination

6. COARCTATION OF THE AORTA

Heading	Key Points
Etiology	Discrete narrowing at aortic isthmus (juxtaductal); associated with bicuspid aortic valve (50-85%), Turner syndrome, berry aneurysms of Circle of Willis
Epidemiology	5-8% of all CHD; male predominance (2:1); most common structural cause of secondary hypertension in young adults
Pathophysiology	Aortic obstruction → upper body hypertension + LVH; reduced lower body perfusion; collateral formation (rib notching); associated BAV may develop AS/AR
Signs & Symptoms	Headache, epistaxis, upper extremity HTN; reduced/absent femoral pulses; radiofemoral delay; BP differential (arms > legs >20 mmHg); interscapular murmur
Diagnosis	ECG: LVH; CXR: "3 sign", rib notching (4th-8th ribs); Echo/Doppler: estimates gradient; MRI/CTA: definitive
Differential Dx	Essential hypertension, Takayasu arteritis, aortic dissection
Treatment	Surgical repair (resection + anastomosis) or percutaneous stenting (preferred in adults/re-coarctation); antihypertensives for residual HTN
Complications	Persistent hypertension, premature CAD, aortic dissection/aneurysm, intracranial aneurysm rupture, LV failure, re-coarctation
Prevention	Genetic screening in Turner syndrome; folic acid; lifelong cardiology surveillance post-repair

7. TETRALOGY OF FALLOT (TOF)

Heading	Key Points
Etiology	Anterior malalignment of infundibular septum → 4 features: RVOT obstruction + large VSD + overriding aorta + RVH. Associated with 22q11 deletion (15%), trisomy 21, maternal diabetes
Epidemiology	Most common cyanotic CHD in adults; 5-10% of all CHD; without surgery <5% survive to age 40
Pathophysiology	Unrepaired: RVOT obstruction → R-to-L shunt through VSD → systemic cyanosis. Repaired: transannular patch → chronic pulmonary regurgitation → RV dilation and failure
Signs & Symptoms	Unrepaired: cyanosis, clubbing, squatting, polycythemia. Repaired (most adults): exertional dyspnea, palpitations (VT), syncope; PR murmur; RBBB on ECG
Diagnosis	ECG: RBBB post-repair; QRS >180 ms = VT risk marker; CXR: "boot-shaped heart" (unrepaired); cardiac MRI: gold standard for PR fraction + RV volumes
Differential Dx	Other cyanotic CHD, double outlet RV, ARVC (post-repair)
Treatment	Surgical repair in childhood; pulmonary valve replacement (PVR) for severe PR + RV dilation in adults; transcatheter PV implantation; ICD for high-risk VT
Complications	Pulmonary regurgitation + RV failure (most common); VT/sudden death; residual VSD; aortic root dilation; AF; endocarditis
Prevention	Periconceptional folic acid; 22q11 genetic screening; avoidance of teratogens; timely surgical repair in childhood

8. TRANSPOSITION OF THE GREAT ARTERIES (TGA)

Heading	Key Points
Etiology	Abnormal truncoaortic septation: aorta from morphological RV, PA from morphological LV. D-TGA (complete); L-TGA (congenitally corrected). Associated with maternal diabetes
Epidemiology	~5% of all CHD; most common cyanotic CHD in neonates; adults almost universally surgically repaired (Mustard/Senning or arterial switch)
Pathophysiology	D-TGA: parallel circulation (needs mixing via ASD/VSD/PDA); post-atrial switch: morphological RV is systemic ventricle → progressive RV failure. L-TGA (ccTGA): physiologically corrected but morphological RV sustains systemic load
Signs & Symptoms	Post-Mustard/Senning adults: dyspnea, palpitations, syncope, systemic RV failure signs (elevated JVP, edema, TR murmur); cyanosis if baffle leak. ccTGA: RV failure, complete heart block
Diagnosis	ECG: Q waves V1, absent Q in lateral leads (ccTGA); atrial flutter; AV block. Echo: morphological RV as systemic ventricle. MRI: systemic RV quantification (gold standard)
Differential Dx	Dilated cardiomyopathy, other cyanotic CHD, ARVC
Treatment	Pacemaker/ICD for arrhythmias; HF therapy (ACEi, beta-blockers); baffle stenting; cardiac transplant (end-stage); arterial switch neonates (D-TGA)
Complications	Systemic RV failure, sinus node dysfunction, atrial flutter/AF, baffle obstruction/leaks, sudden cardiac death, complete heart block (ccTGA)
Prevention	Avoidance of maternal diabetes; neonatal arterial switch operation (best long-term outcome for D-TGA)

9. EBSTEIN ANOMALY

Heading	Key Points
Etiology	Failed tricuspid leaflet delamination → apical displacement of septal/posterior leaflets into RV. Associated with maternal lithium, WPW syndrome (25%), ASD/PFO (>80%)
Epidemiology	<1% of all CHD; wide clinical spectrum; mild cases discovered incidentally in adults
Pathophysiology	Atrialized RV + severe TR → right atrial dilation → R-to-L shunting (ASD/PFO) → cyanosis; WPW accessory pathways → SVT/AF with rapid conduction
Signs & Symptoms	Exercise intolerance, palpitations (SVT, AF), dyspnea, cyanosis/clubbing; "sail sound" (loud T1); wide split S1; holosystolic TR murmur at LLSB; massive cardiomegaly
Diagnosis	ECG: RBBB, giant P waves, delta waves (WPW), AF/flutter; CXR: "box-shaped" massive cardiomegaly; Echo: apical leaflet displacement >8 mm/m² (diagnostic); MRI: RV volume quantification
Differential Dx	TR from other causes, dilated cardiomyopathy, ARVC, pericardial effusion
Treatment	Mild: observation; catheter ablation for WPW/SVT; tricuspid valve repair (cone reconstruction preferred) + RV plication for severe TR; ASD closure; ICD for VT
Complications	AF/flutter, SVT/sudden death (WPW), RV failure, cyanosis, paradoxical embolism, polycythemia
Prevention	Minimize lithium in first trimester; WPW ablation pre-pregnancy/sports in high-risk patients

Quick Reference Summary Table

Defect	Hallmark Sign	Key Investigation	First-line Treatment
ASD	Fixed split S2	Echo (TTE/TEE)	Percutaneous device closure
PFO	Cryptogenic stroke	TEE bubble study	Percutaneous closure (post-stroke)
VSD	Holosystolic murmur	Echo + Doppler	Transcatheter/surgical closure
PDA	Machinery murmur	Echo/Doppler	Transcatheter coil closure
PS	Ejection click + ESM	Echo gradient	Balloon valvuloplasty
CoA	Radiofemoral delay	MRI/CTA	Stenting or surgical repair
TOF	Boot-shaped heart	Cardiac MRI	Pulmonary valve replacement (adults)
TGA	Systemic RV failure	Cardiac MRI	Pacemaker/ICD + transplant (end-stage)
Ebstein	Box-shaped heart	Echo (leaflet displacement)	TV repair (cone reconstruction)

All adults with CHD require lifelong follow-up at specialized ACHD centers per 2025 AHA/ACC guidelines.

ASD,VSD,TETROLOGY IF FALLOT

Here is a focused, detailed yet concise breakdown of ASD, VSD, and Tetralogy of Fallot under all 9 headings.

1. ATRIAL SEPTAL DEFECT (ASD)

Etiology

Failure of interatrial septum to close during embryogenesis
Subtypes:
- Ostium secundum (70%) — fossa ovalis deficiency (most common)
- Ostium primum — endocardial cushion failure; linked to Down syndrome
- Sinus venosus — near SVC/IVC junction
- Coronary sinus type — rarest
Genetic: Trisomy 21, Turner syndrome (45,X), 22q11 deletion
Environmental: Maternal rubella, diabetes, alcohol, thalidomide

Epidemiology

30-40% of all congenital heart disease in adults
Ostium secundum = 7% of all congenital lesions
Female predominance (2:1)
Most common CHD diagnosed in adults (many asymptomatic until 4th-5th decade)
Prevalence: 3-4 per 1000 adults

Pathophysiology

Left atrium (higher pressure) → Right atrium
       ↓
RV volume overload → RV dilation
       ↓
↑ Pulmonary blood flow → Pulmonary hypertension (over decades)
       ↓
Eisenmenger syndrome (shunt reversal R→L) — late, untreated

Atrial arrhythmias (AF/flutter) from chronic right atrial dilation
Risk of paradoxical embolism through the defect

Clinical Signs & Symptoms

Symptoms:

Exertional dyspnea, fatigue, exercise intolerance
Palpitations, syncope (atrial arrhythmias)
Stroke/TIA (paradoxical embolism)
70% become symptomatic by 5th decade

Signs:

Sign	Description
Wide, fixed split S2	Hallmark — does not vary with respiration
Pulmonary flow murmur	Soft ejection systolic, 2nd left interspace
Mid-diastolic tricuspid murmur	Large shunts — lower left sternal border
RV heave	Left parasternal area
Signs of RHF	JVP elevation, edema (advanced)

Diagnosis

Test	Finding
ECG	Incomplete RBBB (rSr' in V1/V2); right axis deviation; prolonged PR; AF/flutter
CXR	Pulmonary plethora; dilated PA and branches; RA/RV enlargement
Echo (TTE/TEE)	Diagnostic — visualizes defect, estimates Qp:Qs, PA pressure
Bubble study	Saline contrast detects R→L shunting
Cardiac MRI	Quantifies RV function and shunt volume
Catheterization	Measures PVR when pulmonary HTN suspected

Differential Diagnosis

Patent foramen ovale (no resting shunt, no RV dilation)
Pulmonary stenosis (S2 splitting not fixed; ejection click present)
Partial anomalous pulmonary venous return (often coexists)
Mitral stenosis (diastolic murmur)
Right heart failure from other causes

Treatment

Indication	Treatment
RV enlargement ± symptoms	Percutaneous device closure (Amplatzer) — 1st line for secundum ASD ≤3.5 cm
Complex anatomy/primum ASD	Surgical closure
Eisenmenger syndrome	Closure CONTRAINDICATED; pulmonary vasodilators (bosentan, sildenafil)
Post-closure	Aspirin for 6 months; lifelong ACHD follow-up

In patients >40 years: closure improves functional status and survival even with symptoms

Complications

Atrial fibrillation/flutter (most common long-term complication)
Pulmonary arterial hypertension
Eisenmenger syndrome (irreversible)
Right heart failure
Paradoxical embolism and stroke
Post-device: embolization, residual shunt, device thrombus

Prevention

Periconceptional folic acid supplementation
Rubella vaccination before pregnancy
Avoid teratogens (alcohol, thalidomide)
Genetic counseling for chromosomal syndromes

2. VENTRICULAR SEPTAL DEFECT (VSD)

Etiology

Incomplete closure of interventricular septum during cardiac embryogenesis
Subtypes:
- Perimembranous (70%) — near aortic valve; most common
- Muscular — within trabecular septum; may be multiple ("Swiss cheese")
- Outlet/supracristal — beneath pulmonary/aortic valve; causes aortic regurgitation
- Inlet (AV canal type) — associated with trisomy 21
Genetic: Trisomy 21 (~40%), trisomy 13 (90%), trisomy 18 (90%), 22q11 deletion
Environmental: Same maternal risk factors as ASD

Epidemiology

Most common CHD overall (15-20% of all CHD in children)
Lower prevalence in adults due to 30-50% spontaneous closure rate in small VSDs by age 10
More prevalent in males slightly; no strong sex dominance
Small VSDs ("maladie de Roger") commonly discovered incidentally in adults

Pathophysiology

LV (high pressure) → RV through defect
       ↓
LV volume overload → LV dilation and failure
       ↓
↑ Pulmonary blood flow → Pulmonary vascular remodeling
       ↓
Pulmonary arterial hypertension
       ↓
Eisenmenger syndrome (R→L shunt) — cyanosis, clubbing

Outlet VSD: Aortic leaflet prolapse into defect → progressive aortic regurgitation
Small VSDs: Minimal hemodynamic effect but increased endocarditis risk

Clinical Signs & Symptoms

Symptoms:

Small VSD: Asymptomatic; incidental murmur
Moderate-large VSD: Exertional dyspnea, fatigue, reduced exercise tolerance, recurrent chest infections
Eisenmenger VSD: Central cyanosis, clubbing, dyspnea at rest, right heart failure, hemoptysis

Signs:

Sign	Description
Harsh holosystolic murmur	3rd-4th LICS, left sternal border; radiates across precordium
Palpable thrill	Small-moderate defects (smaller defect = louder murmur)
Displaced apex	LV dilation
S3 gallop	Large shunts
Cyanosis + clubbing	Eisenmenger physiology
Signs of LHF/RHF	Advanced disease

Diagnosis

Test	Finding
ECG	LVH (volume overload); biventricular hypertrophy (large shunts)
CXR	Cardiomegaly; increased pulmonary vascular markings; dilated PA
Echo/Doppler	Localizes defect; estimates shunt (Qp:Qs); measures PA pressure
Cardiac catheterization	Quantifies PVR; assesses reversibility of pulmonary hypertension
Cardiac MRI	Quantifies LV/RV volumes and shunt fraction

Differential Diagnosis

Mitral regurgitation (murmur radiates to axilla; apex beat displaced)
Aortic stenosis (ejection murmur, not holosystolic)
Hypertrophic obstructive cardiomyopathy (HOCM)
Tricuspid regurgitation (murmur increases with inspiration)
ASD (fixed S2 splitting; diastolic flow murmur)

Treatment

Situation	Treatment
Small VSD, no symptoms, no LV dilation	Observation; endocarditis vigilance
Qp:Qs ≥2:1 or LV volume overload	Surgical or transcatheter VSD closure
Outlet VSD + progressive AR	Surgical repair even if shunt is small
Eisenmenger syndrome	Closure CONTRAINDICATED; pulmonary vasodilators (bosentan, sildenafil, prostacyclins)
Post-repair	Endocarditis prophylaxis for 6 months

Complications

Infective endocarditis (even with small VSDs — risk remains)
Pulmonary arterial hypertension and Eisenmenger syndrome
Aortic regurgitation (outlet VSDs)
Left heart failure
Ventricular arrhythmias (post-repair scar)
Complete heart block (surgical risk near AV node)

Prevention

Folic acid periconceptionally
Avoidance of teratogens
Genetic counseling in trisomy 21 and other chromosomal disorders
Endocarditis prophylaxis for dental/surgical procedures in unrepaired VSDs

3. TETRALOGY OF FALLOT (TOF)

Etiology

Anterior malalignment of the infundibular (outlet) septum during embryogenesis
Results in the 4 classic components:
1. Right ventricular outflow tract (RVOT) obstruction — infundibular/pulmonary valve stenosis
2. Large perimembranous VSD
3. Overriding aorta (aorta straddles the VSD)
4. Right ventricular hypertrophy (secondary)
Genetic associations:
- 22q11.2 deletion (DiGeorge/CATCH-22) — 15% of TOF (higher with right aortic arch)
- Trisomy 21
- JAG1 mutations (Alagille syndrome)
- CHARGE association
Environmental: Maternal diabetes, phenylketonuria, retinoic acid exposure
Sporadic in majority of cases

Epidemiology

Most common cyanotic CHD in adults
Accounts for 5-10% of all CHD
Without surgery: <5% survive to age 40
Most adults with TOF have undergone complete surgical repair in childhood
Adults with repaired TOF are the largest group of complex CHD patients seen in ACHD clinics

Pathophysiology

Unrepaired TOF:

RVOT obstruction → diverts deoxygenated RV blood
       ↓
Through large VSD into overriding aorta
       ↓
Systemic cyanosis + desaturation
       ↓
Compensatory polycythemia + clubbing

Severity of RVOT obstruction determines degree of right-to-left shunting
"Tet spells" (hypercyanotic episodes) — dynamic infundibular spasm in infancy

Repaired TOF (most adults):

Transannular patch repair (RVOT relief)
       ↓
Chronic pulmonary regurgitation (PR)
       ↓
Progressive RV volume overload → RV dilation
       ↓
RV dysfunction + failure + ventricular arrhythmias

VSD patch closure eliminates shunting
RV surgical scar → substrate for re-entrant ventricular tachycardia
QRS duration on ECG reflects degree of RV dilation; QRS >180 ms = high VT/SCD risk

Clinical Signs & Symptoms

Unrepaired (rare in adults):

Central cyanosis, digital clubbing
Exertional dyspnea, polycythemia
Squatting posture (↑ SVR reduces R→L shunting)
Hypercyanotic spells

Repaired TOF (most adult patients):

Symptom/Sign	Notes
Exertional dyspnea	From RV dilation/dysfunction due to chronic PR
Palpitations	From ventricular tachycardia (RV scar)
Presyncope/syncope	Sustained VT or RVOT obstruction
Reduced exercise tolerance	Objective on CPET testing
Diastolic murmur (PR)	Low-pitched, decrescendo at LLSB
RV heave/lift	Dilated, pressure/volume-loaded RV
RBBB on ECG	Nearly universal post-repair
Signs of RV failure	↑ JVP, peripheral edema, hepatomegaly (late)

Diagnosis

Test	Finding
ECG	RBBB (universal post-repair); right axis deviation; QRS >180 ms = VT/SCD risk marker
CXR	"Boot-shaped heart" (coeur en sabot) — unrepaired; right aortic arch in 25%; post-repair: RV enlargement
Echo	Residual VSD; RVOT obstruction severity; pulmonary regurgitation; RV size/function; aortic root dilation
Cardiac MRI	Gold standard — quantifies PR fraction; RV end-diastolic volume (>160-170 mL/m² = threshold for PVR)
Holter/EP study	VT risk stratification; pre-operative assessment; QRS >160 ms triggers EP evaluation
CPET	Objective exercise capacity; peak VO2 guides timing of pulmonary valve replacement

Differential Diagnosis

Other cyanotic CHD (pulmonary atresia with VSD, truncus arteriosus, double outlet RV)
Double outlet right ventricle with pulmonary stenosis (closely related, may mimic TOF)
Pentalogy of Fallot (TOF + ASD)
ARVC (post-repair — RV dilation, VT, RBBB overlap)
Isolated RVOT obstruction

Treatment

Stage	Treatment
Children	Complete surgical repair: VSD patch closure + RVOT/pulmonary valve relief
Adults — severe PR + RV dilation	Pulmonary valve replacement (PVR) — surgical or transcatheter (Melody/SAPIEN valve)
PVR timing	RV EDVI >160-170 mL/m², worsening RV function, declining exercise capacity, symptoms
Ventricular arrhythmias	Antiarrhythmic drugs; VT ablation (RV scar substrate); ICD for high-risk patients
ICD indications	Survivors of cardiac arrest; sustained VT; QRS >180 ms + severe PR + LV dysfunction
Atrial arrhythmias	Rhythm control; ablation; anticoagulation if AF
Aortic root dilation	Aortic valve/root repair or replacement if severe AR
Eisenmenger (rare)	Pulmonary vasodilators; transplantation

Complications

Complication	Notes
Pulmonary regurgitation + RV failure	Most common long-term complication post-repair
Ventricular tachycardia / SCD	From RV scar; QRS >180 ms is the key risk marker
Residual or recurrent RVOT obstruction	May need re-intervention
Residual VSD	Patch dehiscence
Atrial fibrillation/flutter	From RA dilation
Aortic root dilation + AR	Due to bicuspid aortic valve or intrinsic aortopathy
Infective endocarditis	Especially with residual defects
Brain abscess	Paradoxical emboli in unrepaired/cyanotic disease
Polycythemia + hyperviscosity	In unrepaired/cyanotic patients

Prevention

Periconceptional folic acid supplementation
Screening for 22q11 deletion in affected families (genetic counseling)
Avoidance of known teratogens (alcohol, retinoic acid)
Timely complete surgical repair in infancy/early childhood to prevent long-term RV damage
Lifelong ACHD specialist follow-up after repair — annual cardiac MRI and ECG monitoring

Side-by-Side Comparison

Feature	ASD	VSD	TOF
Shunt direction	L→R (atrial)	L→R (ventricular)	R→L (via VSD + overriding Ao)
Hallmark murmur	Fixed split S2 + pulmonary flow murmur	Harsh holosystolic LSB murmur	Ejection systolic (RVOT) + absent/soft P2
Key CXR sign	Pulmonary plethora	Cardiomegaly + plethora	Boot-shaped heart
Key ECG sign	Incomplete RBBB	LVH	RBBB (post-repair); right axis
Gold standard imaging	Echo/TEE	Echo/Doppler	Cardiac MRI
Eisenmenger risk	Yes (late)	Yes (earlier, large defects)	Rare (fixed obstruction limits flow)
1st-line treatment	Percutaneous device closure	Transcatheter/surgical closure	Pulmonary valve replacement (adults)
Main adult complication	AF + pulmonary HTN	Endocarditis + Eisenmenger	Pulmonary regurgitation + VT/SCD

All three defects require lifelong follow-up at specialized Adult Congenital Heart Disease (ACHD) centers per the 2025 AHA/ACC guidelines.

This is a shared conversation. Sign in to Orris to start your own chat.